The U.S. Defense Logistics Agency (DLA) awarded a $8,427 fixed-price delivery order contract to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, which has an ultimate completion date of November 18, 2024, is for the delivery of the SIMPLIFY medical device. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is not set aside for any specific business category. The contract is part of a larger $8 million Blanket Purchase Agreement (BPA) that Nuvasive holds with the Defense Health Agency (DHA), which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. This BPA allows DHA and Department of Veterans Affairs (VA) medical facilities to efficiently access Nuvasive's portfolio of spinal medical devices and instruments to support orthopedic, neurological, and reconstructive surgeries for military health system patients.
Generated 1/17/25, 9:15 AM